BIOMAT Database Logo BIOMAT Database Logo

[Clinico-immunological criteria of the effectiveness of chemotherapy in patients with destructive pulmonary tuberculosis]. 1986

O M Ivaniuta, and L S Kogosova, and I G Il'nitskiĭ, and Iu L Zamdborg, and R S Davyda

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune

Related Publications

O M Ivaniuta, and L S Kogosova, and I G Il'nitskiĭ, and Iu L Zamdborg, and R S Davyda
[Effectiveness of various chemotherapy programs in patients with disseminated destructive pulmonary tuberculosis].
January 1985, Problemy tuberkuleza,
O M Ivaniuta, and L S Kogosova, and I G Il'nitskiĭ, and Iu L Zamdborg, and R S Davyda
Effects of chemotherapy on the immunological characteristics of patients with primary destructive pulmonary tuberculosis.
January 1984, Bulletin of the World Health Organization,
O M Ivaniuta, and L S Kogosova, and I G Il'nitskiĭ, and Iu L Zamdborg, and R S Davyda
[Effectiveness of short-term chemotherapy in patients with newly detected destructive pulmonary tuberculosis].
January 1984, Problemy tuberkuleza,
O M Ivaniuta, and L S Kogosova, and I G Il'nitskiĭ, and Iu L Zamdborg, and R S Davyda
[Effectiveness of different chemotherapy regimens in newly detected patients with destructive pulmonary tuberculosis].
January 1987, Problemy tuberkuleza,
O M Ivaniuta, and L S Kogosova, and I G Il'nitskiĭ, and Iu L Zamdborg, and R S Davyda
[Effectiveness of chemotherapy in newly detected destructive pulmonary tuberculosis].
June 1978, Problemy tuberkuleza,
O M Ivaniuta, and L S Kogosova, and I G Il'nitskiĭ, and Iu L Zamdborg, and R S Davyda
[Immunological status of newly detected patients with destructive pulmonary tuberculosis].
April 1979, Problemy tuberkuleza,
O M Ivaniuta, and L S Kogosova, and I G Il'nitskiĭ, and Iu L Zamdborg, and R S Davyda
[Effectiveness of the chemotuberculinotherapy of patients with destructive pulmonary tuberculosis].
January 1985, Problemy tuberkuleza,
O M Ivaniuta, and L S Kogosova, and I G Il'nitskiĭ, and Iu L Zamdborg, and R S Davyda
[Effectiveness of chemotherapy of patients with newly detected destructive pulmonary tuberculosis living in rural areas].
January 1990, Problemy tuberkuleza,
O M Ivaniuta, and L S Kogosova, and I G Il'nitskiĭ, and Iu L Zamdborg, and R S Davyda
[Methods of evaluation of the effectiveness of chemotherapy of patients with newly detected destructive pulmonary tuberculosis].
March 1974, Problemy tuberkuleza,
O M Ivaniuta, and L S Kogosova, and I G Il'nitskiĭ, and Iu L Zamdborg, and R S Davyda
[Effectiveness of tuberculin and chemotherapy in destructive forms of pulmonary tuberculosis].
April 1981, Problemy tuberkuleza,
Copied contents to your clipboard!